A Phase I/II Study to Evaluate the Safety, Tolerability and Efficacy of PerioSept and Scaling and Root Planing in Subjects With Periodontitis

Trial Profile

A Phase I/II Study to Evaluate the Safety, Tolerability and Efficacy of PerioSept and Scaling and Root Planing in Subjects With Periodontitis

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 06 May 2017

At a glance

  • Drugs Taurolidine (Primary)
  • Indications Periodontitis
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Geistlich
  • Most Recent Events

    • 15 Feb 2017 Planned End Date changed from 1 Dec 2016 to 1 Feb 2018.
    • 15 Feb 2017 Planned primary completion date changed from 1 Nov 2016 to 1 Nov 2017.
    • 24 Jul 2015 Planned End Date changed from 1 Feb 2016 to 1 Dec 2016 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top